Evaluation of residual effect of perioperative anticoagulat and antiplatelet drugs by using Sonoclot.
Not Applicable
Recruiting
- Conditions
- Patients who are given anticoagulants or antiplatelet drugs in elective operations.
- Registration Number
- JPRN-UMIN000028321
- Lead Sponsor
- Sapporo Medical University, School of Medicine, Department of Anesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who can not obtain consent, emergency operation patients, patients with anemia, patients who have received transfusion within 2 weeks, patients with diagnosed blood / coagulation abnormality, patients with renal dysfunction, dialysis patients, hepatic dysfunction, patients who have stopped anticoagulant / antiplatelet drugs but who do not satisfy the drug holiday period specified in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The results of Sonoclot including activated clotting time (ACT), clot rate, platelet function.
- Secondary Outcome Measures
Name Time Method Types of anticoagulant / antiplatelet drugs, drug holiday, presence or absence of heparin substitution, disease name, operation type, bleeding volume, blood transfusion volume.